0001924725-26-000004.txt : 20261014 0001924725-26-000004.hdr.sgml : 20261014 20261014143254 ACCESSION NUMBER: 0001924725-26-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261014 DATE AS OF CHANGE: 20261014 EFFECTIVENESS DATE: 20261014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Myris Therapeutics, Inc. CENTRAL INDEX KEY: 0001924725 ORGANIZATION NAME: EIN: 874758547 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-601204 FILM NUMBER: 261459506 BUSINESS ADDRESS: STREET 1: 307 23RD ST. EXT STREET 2: SUITE 150 CITY: SHARPSBURG STATE: PA ZIP: 15215 BUSINESS PHONE: 412-816-5315 MAIL ADDRESS: STREET 1: 307 23RD ST. EXT STREET 2: SUITE 150 CITY: SHARPSBURG STATE: PA ZIP: 15215 FORMER COMPANY: FORMER CONFORMED NAME: BioHybrid Solutions Holdings, Inc. DATE OF NAME CHANGE: 20220429 FORMER COMPANY: FORMER CONFORMED NAME: Biohybrid Solutions Holdings, Inc. DATE OF NAME CHANGE: 20220420 D 1 primary_doc.xml X0708 D LIVE 0001924725 Myris Therapeutics, Inc. 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 412-816-5315 DELAWARE BioHybrid Solutions Holdings, Inc. Biohybrid Solutions Holdings, Inc. Corporation true 2022 Laura E. Benjamin 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Executive Officer Director Rebecca Wolfe 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Executive Officer Antonina Simakova 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Executive Officer Alan Russell 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Promoter David N. Colaizzi 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Director Barbara S. Fox 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Director Krzysztof Matyjaszewski 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Director Mark A. Murcko 307 23RD ST. EXT SUITE 150 SHARPSBURG PA PENNSYLVANIA 15215 Director Biotechnology Decline to Disclose 06b false 2026-09-01 false true Convertible Promissory Notes false 0 4500000 500000 4000000 false 4 0 0 0 false Myris Therapeutics, Inc. /s/ Laura E. Benjamin Laura E. Benjamin President and Chief Executive Officer 2026-10-14